EGFR and lung cancer: Perhaps the most significant result was that the PW laser reduced the viability of 93%±12% of the population of lung cancer cells when combined with anti-EGFR targeting S-Au40-849s (after 24 h incubation), in comparison to the CW which destroyed almost half (46%) of the cells.